期刊
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
卷 31, 期 -, 页码 82-87出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.bpobgyn.2015.11.010
关键词
mesenchymal stem cells; multipotent mesenchymal stromal cells; foetal stem cells; perinatal stem cells; osteogenesis imperfecta
资金
- Vinnova [2010-00501]
- Swedish Research Council [921-2014-7209]
Finding suitable cell sources is one of the main challenges in regenerative medicine. In addition to improving the dysfunctional tissue requiring reconstruction, low immunogenicity is beneficial. Mesenchymal stem cells (MSCs) are immune-privileged multi potent stromal cells that can easily multiply and differentiate along many lineages with a minimal oncogenic risk. MSC5 derived from foetal tissues present characteristics that suggest an even stronger cell therapeutic potential in comparison to adult MSC5. Due to these characteristics, they have been and are currently being tested in clinical trials for a diverse variety of disorders. (C) 2015 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据